Analyst Consensus ?
ConsensusHold50 ratings
Bullish2856.0%
Neutral1938.0%
Bearish36.0%
FN2 Earnings Intelligence
Insulet Corp. complete analyst coverage
Insulet Corp. (PODD) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$152.5Current
$144Low
$241.72Average
$450High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Jefferies | Buy | Buy | Maintain | Oct 12, 2026 |
| Wells Fargo | Equal Weight | Overweight | Downgrade | Aug 6, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Truist Securities | Hold | Buy | Downgrade | Aug 6, 2026 |
| TD Cowen | Hold | Hold | Maintain | Aug 6, 2026 |
| Stifel | Buy | Buy | Maintain | Aug 6, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 6, 2026 |
| Leerink Partners | Market Perform | Outperform | Downgrade | Aug 6, 2026 |
| JP Morgan | Neutral | Overweight | Downgrade | Aug 6, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Aug 6, 2026 |
| BTIG | Neutral | Buy | Downgrade | Aug 6, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Aug 6, 2026 |
| Benchmark | Buy | Buy | Maintain | Aug 6, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 8, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 18, 2026 |
| Barclays | Underweight | Underweight | Maintain | May 8, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | May 7, 2026 |
| Rothschild & Co | Neutral | Buy | Downgrade | Apr 24, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 9, 2026 |
| Raymond James | Outperform | Outperform | Maintain | May 27, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | May 13, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 21, 2025 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 11, 2024 |
| OTR Global | Mixed | Positive | Downgrade | Jun 10, 2024 |
| Baird | Outperform | Neutral | Upgrade | Dec 21, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | May 6, 2022 |
| CFRA | Sell | Sell | Maintain | May 8, 2020 |
| Piper Jaffray | Overweight | Overweight | Maintain | Nov 18, 2019 |
| Guggenheim Securities | Neutral | Buy | Downgrade | Oct 3, 2019 |
| Guggenheim | Neutral | Buy | Downgrade | Oct 3, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 6, 2019 |
| Northland Capital Markets | Market Perform | Outperform | Downgrade | Jun 10, 2019 |
| Northland | Market Perform | Outperform | Downgrade | Jun 10, 2019 |
| BTIG Research | Buy | Neutral | Upgrade | May 6, 2019 |
| Berenberg | Buy | Buy | Maintain | Apr 20, 2018 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Feb 22, 2018 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 22, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Sep 27, 2016 |
| William Blair | Outperform | Market Perform | Upgrade | Apr 29, 2016 |
| Empire Asset Management | Sell | Sell | Maintain | Feb 25, 2016 |
| PiperJaffray | Overweight | Overweight | Maintain | Aug 13, 2015 |
| Northland Securities | Outperform | Market Perform | Upgrade | May 4, 2015 |
| Leerink Swann | Outperform | Outperform | Maintain | Jan 21, 2015 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Nov 6, 2014 |
| Wedbush | Outperform | Outperform | Maintain | Oct 28, 2014 |
| Barrington Research | Outperform | Market Perform | Upgrade | May 16, 2014 |
| Feltl & Co. | Hold | Sell | Upgrade | May 8, 2014 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jun 7, 2013 |
| Wunderlich | Hold | Buy | Downgrade | Jun 7, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $152.5. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Jefferies | Matthew Taylor | $190 | $135.28 | +24.6% | Oct 12, 2026 |
| Barclays | Analyst unavailable | $150 | $134.73 | -1.6% | Oct 6, 2026 |
| Robert W. Baird | Jeff Johnson | $175 | $134.95 | +14.8% | Aug 6, 2026 |
| Bernstein | Analyst unavailable | $175 | $131.75 | +14.8% | Aug 6, 2026 |
| Leerink Partners | Mike Kratky | $145 | $133.26 | -4.9% | Aug 6, 2026 |
| RBC Capital | Analyst unavailable | $160 | $133.26 | +4.9% | Aug 6, 2026 |
| Raymond James | Jayson Bedford | $180 | $133.26 | +18.0% | Aug 6, 2026 |
| Canaccord Genuity | William Plovanic | $179 | $133.26 | +17.4% | Aug 6, 2026 |
| Wells Fargo | Larry Biegelsen | $144 | $133.26 | -5.6% | Aug 5, 2026 |
| Truist Financial | Analyst unavailable | $153 | $133.26 | +0.3% | Aug 5, 2026 |
| UBS | Analyst unavailable | $174 | $165 | +14.1% | Jul 28, 2026 |
| Truist Financial | Analyst unavailable | $210 | $162.79 | +37.7% | Jul 13, 2026 |
| RBC Capital | Analyst unavailable | $245 | $163.11 | +60.7% | Jul 13, 2026 |
| Stifel Nicolaus | Analyst unavailable | $225 | $158.29 | +47.5% | Jul 10, 2026 |
| Evercore ISI | Analyst unavailable | $180 | $155.44 | +18.0% | Jul 6, 2026 |
| Deutsche Bank | Analyst unavailable | $190 | $138.97 | +24.6% | Jun 23, 2026 |
| UBS | Analyst unavailable | $219 | $149.73 | +43.6% | Jun 11, 2026 |
| Truist Financial | Richard Newitter | $219 | $149.19 | +43.6% | Jun 11, 2026 |
| Raymond James | Analyst unavailable | $216 | $151.51 | +41.6% | Jun 8, 2026 |
| Goldman Sachs | David Roman | $205 | $153.8 | +34.4% | May 27, 2026 |
| BTIG | Analyst unavailable | $235 | $153.8 | +54.1% | May 26, 2026 |
| Goldman Sachs | Analyst unavailable | $237 | $160.4 | +55.4% | May 7, 2026 |
| RBC Capital | Shagun Singh | $280 | $161.1 | +83.6% | May 7, 2026 |
| Truist Financial | Richard Newitter | $250 | $157.3 | +63.9% | May 7, 2026 |
| Evercore ISI | Analyst unavailable | $200 | $156.7 | +31.1% | May 7, 2026 |
| Oppenheimer | Analyst unavailable | $210 | $151.28 | +37.7% | May 7, 2026 |
| Stifel Nicolaus | Analyst unavailable | $250 | $151.28 | +63.9% | May 7, 2026 |
| Canaccord Genuity | William Plovanic | $249 | $151.28 | +63.3% | May 7, 2026 |
| Bernstein | Analyst unavailable | $200 | $151.28 | +31.1% | May 7, 2026 |
| Barclays | Matt Miksic | $198 | $151.28 | +29.8% | May 7, 2026 |
| BTIG | Analyst unavailable | $260 | $152.67 | +70.5% | May 6, 2026 |
| Redburn Partners | Analyst unavailable | $220 | $192.21 | +44.3% | Apr 24, 2026 |
| Truist Financial | Richard Newitter | $315 | $202.28 | +106.6% | Apr 15, 2026 |
| RBC Capital | Shagun Singh | $325 | $197.81 | +113.1% | Apr 14, 2026 |
| Truist Financial | Analyst unavailable | $360 | $246.04 | +136.1% | Feb 19, 2026 |
| Evercore ISI | Analyst unavailable | $340 | $251.21 | +123.0% | Feb 19, 2026 |
| Goldman Sachs | David Roman | $326 | $251.38 | +113.8% | Feb 19, 2026 |
| Oppenheimer | Analyst unavailable | $300 | $254.59 | +96.7% | Feb 19, 2026 |
| Bernstein | Analyst unavailable | $330 | $258.07 | +116.4% | Feb 19, 2026 |
| Barclays | Analyst unavailable | $286 | $258.07 | +87.5% | Feb 19, 2026 |
| Canaccord Genuity | William Plovanic | $435 | $258.07 | +185.2% | Feb 18, 2026 |
| Stifel Nicolaus | Analyst unavailable | $350 | $249.07 | +129.5% | Feb 4, 2026 |
| Barclays | Analyst unavailable | $274 | $286.92 | +79.7% | Jan 12, 2026 |
| Bernstein | Lee Hambright | $380 | $292.89 | +149.2% | Jan 9, 2026 |
| Goldman Sachs | David Roman | $365 | $292.89 | +139.3% | Jan 9, 2026 |
| Truist Financial | Analyst unavailable | $390 | $296.42 | +155.7% | Dec 18, 2025 |
| Canaccord Genuity | Analyst unavailable | $450 | $288.73 | +195.1% | Dec 17, 2025 |
| Evercore ISI | Analyst unavailable | $370 | $295.31 | +142.6% | Dec 16, 2025 |
| Canaccord Genuity | Analyst unavailable | $432 | $331.17 | +183.3% | Nov 24, 2025 |
| Truist Financial | Richard Newitter | $412 | $325 | +170.2% | Nov 21, 2025 |
| RBC Capital | Shagun Singh | $380 | $324.2 | +149.2% | Nov 21, 2025 |
| BTIG | Analyst unavailable | $380 | $312.89 | +149.2% | Nov 21, 2025 |
| UBS | Analyst unavailable | $400 | $333.47 | +162.3% | Nov 19, 2025 |
| Jefferies | Matthew Taylor | $400 | $323.4 | +162.3% | Nov 6, 2025 |
| BTIG | Marie Thibault | $370 | $323.4 | +142.6% | Nov 6, 2025 |
| Barclays | Matt Miksic | $301 | $320.27 | +97.4% | Nov 5, 2025 |
| RBC Capital | Analyst unavailable | $365 | $318 | +139.3% | Oct 10, 2025 |
| Canaccord Genuity | Analyst unavailable | $399 | $318 | +161.6% | Sep 29, 2025 |
| Wells Fargo | Analyst unavailable | $322 | $259.52 | +111.1% | Apr 28, 2025 |
| BTIG | Marie Thibault | $270 | $268.96 | +77.0% | Nov 8, 2024 |
| Bernstein | Lee Hambright | $300 | $241.32 | +96.7% | Nov 5, 2024 |
| Raymond James | Jayson Bedford | $260 | $231.61 | +70.5% | Oct 14, 2024 |
| Piper Sandler | Matt O'Brien | $285 | $233.89 | +86.9% | Sep 17, 2024 |
| Piper Sandler | Matt O'Brien | $230 | $193.52 | +50.8% | Aug 27, 2024 |
| Oppenheimer | Steven Lichtman | $233 | $193.54 | +52.8% | Aug 27, 2024 |
| Jefferies | Matthew Taylor | $260 | $193.54 | +70.5% | Aug 27, 2024 |
| BTIG | Marie Thibault | $250 | $199.79 | +63.9% | Aug 9, 2024 |
| Barclays | Matt Miksic | $200 | $165.9 | +31.1% | May 13, 2024 |
| Wolfe Research | Mike Polark | $200 | $176.4 | +31.1% | May 7, 2024 |
| Canaccord Genuity | Kyle Rose | $226 | $166.64 | +48.2% | Mar 21, 2024 |
| Morgan Stanley | Analyst unavailable | $320 | $295 | +109.8% | Jan 6, 2023 |
| Piper Sandler | Matt O'Brien | $340 | $255.35 | +123.0% | Nov 3, 2022 |
| Morgan Stanley | Cecilia Furlong | $273 | $224.16 | +79.0% | Oct 17, 2022 |
| Raymond James | Jayson Bedford | $280 | $260.03 | +83.6% | Aug 23, 2022 |
| Bank of America Securities | Travis Steed | $300 | $265.39 | +96.7% | Mar 3, 2022 |
| UBS | Matthew Taylor | $325 | $253.19 | +113.1% | Feb 2, 2022 |
| Oppenheimer | Steven Lichtman | $275 | $248 | +80.3% | Jan 31, 2022 |
| Canaccord Genuity | Kyle Rose | $330 | $259.14 | +116.4% | Dec 6, 2021 |
| Berenberg Bank | Ravi Misra | $295 | $313.47 | +93.4% | Nov 8, 2021 |
| Citigroup | Joanne Wuensch | $350 | $308 | +129.5% | Nov 5, 2021 |
| Jefferies | Raj Denhoy | $340 | $297.51 | +123.0% | Oct 12, 2021 |
| Cowen & Co. | Josh Jennings | $310 | $271.48 | +103.3% | Jul 21, 2021 |
| Thrivent | JP McKim | $250 | $234.19 | +63.9% | May 7, 2021 |
Track every rating change on PODD the moment it posts. Free to start.
Start freeGet the PODD recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.